Click a keyword to view all the abstracts on this site tagged with that keyword.
- 1-Methyl-4-phenylpyridinium (MPP+)
- Acanthocytosis
- Acetylcholine
- Adenosine antagonists
- Adenosine receptor
- Adenosine triphosphate (ATP)
- Aging
- Alpha-synuclein
- Amantadine
- Amino acid disorders
- Amygdala
- Amyotrophic lateral sclerosis
- Anhedonia
- Anticholinergic medications
- Antidepressants
- Anxiety
- Apathy
- Aphasia
- Apomorphine
- Apoptosis
- Apraxia
- Ataxia: Anatomy
- Ataxia: Clinical features
- Ataxia: Etiology and Pathogenesis
- Ataxia: Genetics
- Ataxia: Pathophysiology
- Ataxia: Treatment
- Attention deficit and hyperactivity disorder (ADHD)
- Autism
- Autonomic dysfunction
- Autonomic nervous system
- Ballism
- Basal ganglia
- Bcl-2 family
- Behavioral abnormalities
- Benzodiazepines
- Bereitschaftpotential (BSP)
- Beta-blockers
- Blepharospasm
- Blink rate
- Botulinum toxin: Chemical subtypes
- Botulinum toxin: Clinical applications: dystonia
- Botulinum toxin: Clinical applications: other
- Botulinum toxin: Clinical applications: spasticity
- Botulinum toxin: Mechanism of action
- Bradykinesia
- Brain iron accumulation
- Brainstem nuclei
- Brainstem reflexes
- Bruxism
- Caffeine
- Calcium
- Caspase family
- Catalase
- Catatonia
- Catechol-O-methyltransferase (COMT)
- Cell death
- Cell replacement therapy
- Cerebellar tremors(see Tremor)
- Cerebellum
- Cerebral palsy
- Ceruloplasmin
- Cholinesterase inhibitors
- Chorea (also see specific diagnoses
- Chorea (also see specific diagnoses, Huntingtons disease, etc): Anatomy
- Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features
- Chorea (also see specific diagnoses, Huntingtons disease, etc): Etiology and Pathogenesis
- Chorea (also see specific diagnoses, Huntingtons disease, etc): Genetics
- Chorea (also see specific diagnoses, Huntingtons disease, etc): Pathophysiology
- Chorea (also see specific diagnoses, Huntingtons disease, etc): Treatment
- Chorea-acanthocytosis (see neuroacanthocytosis)
- Choreoathetosis
- Clonazepam
- Clozapine
- Coenzyme Q10
- Cofactor disorders
- Cognitive dysfunction
- COMT inhibitors
- Constipation
- Contracture
- Copper
- Copper chelation therapy
- Cortical myoclonus (see myoclonus)
- Corticobasal degeneration (CBD)
- Corticosteroids
- Cramps
- Creatine
- Dantrolene
- Dardarin mutation (see LRRK2)
- Deep brain stimulation (DBS)
- Dementia
- Dementia with Lewy bodies (DLB)
- Denervation
- Depression
- Development
- Disease-modifying strategies
- Disinhibition
- DJ-1 mutation
- Dopa decarboxylase(DDC)
- Dopa-responsive dystonia(DRD)
- Dopamine
- Dopamine agonists
- Dopamine dysregulation syndrome
- Dopamine receptor
- Dopamine receptor antagonists
- Dopaminergic neurons
- Dopaminergics
- Drug-induced parkinsonism(DIP)
- Dysarthria
- Dysautonomia(see autonomic dysfunction)
- Dysexecutive syndrome
- Dyskinesias
- Dyskinetic cerebral palsy syndrome
- Dysphagia
- Dysport
- Dystonia musculorum deformans
- Dystonia: Anatomy
- Dystonia: Clinical features
- Dystonia: Etiology and Pathogenesis
- Dystonia: Genetics
- Dystonia: Pathophysiology
- Dystonia: Treatment
- Dystonic tremor
- Early-onset cerebellar ataxia(EOCA)
- Electroencephalogram(EEG)
- Electromyogram(EMG)
- Entacapone
- Environmental toxins
- Episodic ataxia
- Essential tremor(ET)
- Estrogen
- etc): Anatomy
- etc): Clinical features
- etc): Etiology and Pathogenesis
- etc): Genetics
- etc): Pathophysiology
- etc): Treatment
- Evoked potentials
- Excessive daytime sleepiness(EDS)
- Executive functions
- Experimental therapeutics
- Eye movement
- Familial neurodegenerative diseases
- Fetal mesencephalic cell implantation
- Fludrocortisone
- Flunarizine
- Fragile X tremor ataxia syndrome
- Free radicals
- Frontal Assessment Battery(FAB)
- Frontotemporal dementias: Clinical features
- Frontotemporal dementias: Etiology and Pathogenesis
- Frontotemporal dementias: Genetics
- Functional magnetic resonance imaging(fMRI)
- Gait disorders: Anatomy
- Gait disorders: Clinical features
- Gait disorders: Etiology and Pathogenesis
- Gait disorders: Genetics
- Gait disorders: Pathophysiology
- Gait disorders: Treatment
- Gamma-aminobutyric acid(GABA)
- Gastrointestinal problemsm(also see autonomic dysfunction)
- Glial-derived neurotrophic factor(GDNF)
- Globus pallidus
- Glutamate
- Glutamate antagonists
- Glutamic acid decarboxylase
- Glutathione
- Guillain-Barr� syndrome
- Guillain-Mollaret triangle
- Hallervorden-Spatz disease
- Hallucinations
- Heat shock proteins(HSP)
- Heavy metals
- Hemiballism
- Hemichorea
- Hemifacial spasm(HFS)
- Hippocampus
- Holmes tremor
- Huntingtons disease
- Hyperekplexia
- Hypocalcemia
- Hypokinesia
- Immunoglobulins
- Immunosuppression
- Implanted pulse generators(IPG)
- Inferior olive
- Inflammation
- Insulin-dependent diabetes mellitus(IODM)
- Intention tremors(also see tremors)
- Interventions
- Iron
- Ischemia
- Kinase
- Kinetic tremors(see tremors)
- L-threo-34-dihydroxyphenylserine(L-DOPS)
- Lactate dehydrogenase(LDH)
- Leucine-rich repeat kinase 2(LRRK2)
- Levodopa(L-dopa)
- Lewy bodies
- Lipid metabolism
- Liver transplantation
- Locomotion
- Long latency
- Long-term potentiation(LTP)
- Lysosomal disorders
- Mad cow disease.
- Magnetic resonance imaging(MRI)
- Magnetoencephalogram(MEG)
- Manganese
- Manganism
- MAO-B inhibitors
- Medium spiny striatal neurons
- Memory disorders
- Methylprednisolone
- Microelectrode recording
- Microglia
- Microglial activation
- Micturition disturbances(see Autonomic dysfunction)
- Midbrain tremor
- Minocycline
- Mitochondria
- Mitochondrial DNA(mtDNA)
- Mitochondrial dysfunction
- Motoneuron disease
- Motor control
- Motor cortex
- Motor pattern generators(MPG)
- Motor-evoked potential(MEP)
- Multidisciplinary Approach
- Multiple sclerosis(MS)
- Multiple system atrophy(MSA): Anatomy
- Multiple system atrophy(MSA): Clinical features
- Multiple system atrophy(MSA): Etiology and Pathogenesis
- Multiple system atrophy(MSA): Genetics
- Multiple system atrophy(MSA): Pathophysiology
- Multiple system atrophy(MSA): Treatment
- Myalgia
- Myasthenia gravis
- Myoclonic epilepsy
- Myoclonus: Anatomy
- Myoclonus: Clinical features
- Myoclonus: Etiology and Pathogenesis
- Myoclonus: Genetics
- Myoclonus: Pathophysiology
- Myoclonus: Treatment
- Myorhythmia
- Myotonic disorders
- Negative slope(NS)
- Neuroacanthocytosis: Clinical features
- Neuroacanthocytosis: Treatment
- Neurobehavioral disorders
- Neurofibrillary tangles(NFT)
- Neurogenesis
- Neuroleptic malignant syndrome(NMS)
- Neuromelanin
- Neuronal ceroid lipofuscinosis
- Neurophysiology
- Neuroprotective agents
- Neurospheres
- Neurostimulation
- Nicotine
- Nigrostriatal dopaminergic synapse deficiency
- NMDA
- Non-motor Scales
- Obsessive-compulsive behavior/disorder
- Occupational Therapy
- Olazapine
- Olfactory dysfunction
- Organic acid disorders
- Orobuccolingual dyskinesia
- Orthostatic hypotension(OH)
- Orthostatic tremor (also see Tremors)
- Oscillopsia
- Oxidative stress
- Pain
- Palatal tremor(see Tremors)
- Pallidotomy
- Pallidum
- Pantothenate kinase-associated neurodegenetration(PKAN)
- Paraquat
- Parkin
- Parkinson’s
- Parkinsonism
- Parkinsonism dementia complex(PDC)
- Paroxysmal dyskinesia
- Paroxysmal exercise-induced dyskinesia(PED)
- Paroxysmal kinesigenic dyskinesia(PKD)
- Pathological tearing
- Pediatric autoimmune neuropsychiatric disorder
- Pediatric neurotransmitter diseases
- Penicillamine
- Periodic limb movements in sleep(PLMS)
- Peripheral nerve injury
- Peripheral neuropathy
- Pharmacotherapy
- Pisa syndrome
- Pittsburgh Sleep Quality Index(PSQI)
- Plaques
- Polyneuropathy
- Pontine nuclei
- Positron emission tomography(PET)
- Postinfectious disorders
- Posttraumatic tremors
- Postural tremors(see Tremors)
- Posture
- Pramipexole
- Prefrontal cortex(PFC)
- Premotor potentials
- Presynaptic dopaminergic system
- Primary progressive aphasia
- Primary torsion dystonia(PTD)
- Primary writing tremor
- Primidone
- Prion diseases. See Transmissible spongiform encephalopathies
- Prion protein gene(PRNP)
- Progressive encephalomyelitis with rigidity and myoclonus(PERM)
- Progressive lenticular degeneration
- Progressive supranuclear palsy(PSP)
- Propranolol
- Prostatic hyperplasia
- Psychic akinesia
- Psychogenic movement disorders(PMD): Anatomy
- Psychogenic movement disorders(PMD): Clinical features
- Psychogenic movement disorders(PMD): Etiology and Pathogenesis
- Psychogenic movement disorders(PMD): Pathophysiology
- Psychogenic movement disorders(PMD): Treatment
- Psychogenic tremor
- Psychosis
- PTEN induced kinase-1(PINK1)
- Purkinje cells
- Quetiapine
- Ramsay Hunt syndrome
- Rapid eye movement(REM)
- Rapid-onset dystonia-parkinsonism(RDP)
- Rasagiline
- Reaction time
- Red nuclei
- Rehabilitation
- Repetitive transcranial magnetic stimulation(rTMS)
- Resting brain metabolism
- Resting tremors
- Restless legs syndrome(RLS): Clinical features
- Restless legs syndrome(RLS): Etiology and Pathogenesis
- Restless legs syndrome(RLS): Pathophysiology
- Restless legs syndrome(RLS): Treatment
- Reticular formation
- Rhinorrhea
- Rigidity
- Rivastigmine
- Ropinirole
- Rotenone
- Rubral tremor
- Scales
- Sensorimotor cortex
- Sialorrhea
- Simple reaction time(SRT)
- Single-photon emission computed tomography(SPECT)
- Sleep disorders. See also Restless legs syndrome: Anatomy
- Sleep disorders. See also Restless legs syndrome: Clinical features
- Sleep disorders. See also Restless legs syndrome: Etiology and Pathogenesis
- Sleep disorders. See also Restless legs syndrome: Pathophysiology
- Sleep disorders. See also Restless legs syndrome: Treatment
- Somatosensory-evoked potentials(SEP)
- Spasticity: Clinical features
- Spasticity: Etiology and Pathogenesis
- Spasticity: Genetics
- Spasticity: Treatment
- Spinocerebellar ataxia
- Spinocerebellar ataxias(SCA)
- Startle syndromes
- Stem cells. See also Human embryonic stem cells
- Stereotactic neurosurgery
- Stereotypy
- Stiff-person syndrome
- Striatonigral degeneration
- Striatum
- Subcortical motor structures
- Substantia nigra
- Substantia nigra pars compacta(SNpc)
- Subthalamic nucleus(SIN)
- Subthalamotomy
- Superior colliculus(SC)
- Superoxide dismutase
- Surrogate endpoints
- Symptomatic palatal tremor(SPT)
- Synucleinopathies
- Tardive akathisia
- Tardive dyskinesia(TD)
- Tardive dystonia
- Tardive tremor
- Tauopathies
- Tetrabenazine
- Thalamotomy
- Thalamus
- Tics(also see Gilles de la Tourette syndrome): Clinical features
- Tics(also see Gilles de la Tourette syndrome): Etiology and Pathogenesis
- Tics(also see Gilles de la Tourette syndrome): Pathophysiology
- Tics(also see Gilles de la Tourette syndrome): Treatment
- Timed Up and Go test
- Torsion dystonia
- Torticollis
- Toxic envenomation
- Transcranial magnetic stimulation(TMS)
- Tremors: Anatomy
- Tremors: Clinical features
- Tremors: Etiology and Pathogenesis
- Tremors: Genetics
- Tremors: Pathophysiology
- Tremors: Treatment
- Trientine
- Trihexyphenidyl
- Trophic factors
- Ubiquitin proteasome system(UPS)
- Urinary dysfunction pharmacological management of
- Urogenital dysfunction
- Venlafaxine
- Ventralis anterior(VA)
- Ventralis intermedius nucleus(VIM)
- Vesicle monamine transporter(VMAT2)
- Vestibulo-ocular reflex(VOR)
- Visuospatial deficits
- Vitamin E
- Voice tremor
- Wearing-off fluctuations
- Xeomin